Advances in Breast Cancer Therapy (IBRP); Annual rept. 15 Feb 2007-30 Apr 2008

摘要

Therapeutics, Inc. (1) wrote and gained approval for the data safety monitoring plan for this protocol; (2) identified and contracted a medical monitor for this protocol; (3) revised the protocol, informed consent and case report forms, and obtained approval by the USAMRMC ORP HRPO; (4) submitted the protocol and informed consent form to the Western IRB for approval; (5) is collaborating with Windber Research Institute in the preparation of the protocol for the gene chip analysis; (6) secured the vendor for the specimen kits; and negotiated a contract with vendor to provide the electronic data collection, management, and reporting system used for this protocol; and, (7) contracted a medical science liaison for the identification of qualified participating investigators and sites.